Surface Mapping and Sampling Extends Skarn Ridge Corridor an Additional 750m Along Trend: High-Grade Grab Samples Yield 57.8 g/t Au and 109 g/t Au Skarn Ridge is Located 4 kilometres Southwest of the Recently Discovered TESS Zone. The Gap Between These Two Zones Remains Largely Unexplored Vancouver, British Columbia–(Newsfile Corp. …
Read More »Denarius Metals Receives Approval of Final Permit at Its Zancudo Project in Colombia and Is Commencing Construction of Its 1,000 Tonnes per Day Processing Plant to Begin Operations in Second Quarter of 2026
Toronto, Ontario–(Newsfile Corp. – October 20, 2025) – Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) (“Denarius Metals” or the “Company”) announced today that it has received approval of the Industrial Facility Permit for its Zancudo Project from Corantioquia, the local environmental authority in Colombia. With the approval of the …
Read More »Amex Drills 213.11 g/t Au over 3.75 m While Advancing Phase 1 Feasibility Study at Perron
Montréal, Québec–(Newsfile Corp. – October 21, 2025) – Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) (“Amex” or “the Company”) is pleased to announce assay results from a geomechanical drill program conducted on the Champagne Zone as part of its ongoing Phase 1 Feasibility Study on the Perron Project, located …
Read More »First Phosphate Accelerates 30,000 Metre Drilling Program to Provide Final Geological Model for its Begin-Lamarche Igneous Phosphate Property
Saguenay, Quebec–(Newsfile Corp. – October 21, 2025) – First Phosphate Corp. (CSE: PHOS) (OTCQX: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company“) is pleased to announce that it will undertake a 30,000-metre accelerated drill program at its Bégin-Lamarche property in Saguenay-Lac-St-Jean, Quebec, Canada, commencing this month. The drilling program is expected …
Read More »Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, …
Read More »Romios Begins New Round of Fieldwork on the Kinkaid Copper-Gold-Silver Project, Walker Lane Trend, Nevada
Toronto, Ontario–(Newsfile Corp. – October 21, 2025) – Romios Gold Resources Inc. (TSXV: RG) (OTCID: RMIOF) (FSE: D4R) (“Romios Gold” or the “Company”) is pleased to announce that is has begun a 10-day field program of detailed geological mapping and sampling to follow up significant gold assays returned earlier this …
Read More »Minnova Corp. PL Gold Mine Re-Start Plan, In-Fill Drill Program Update, and Option Grant
Toronto, Ontario–(Newsfile Corp. – October 21, 2025) – Minnova Corp. (TSXV: MCI) (OTC Pink: AGRDF) (“Minnova” or the “Company“) is pleased to provide and update on current PL Gold Mine restart plan and a path to near term gold production. PL Gold Mine Restart Plan Update A&B Global Mining (“ABGM”) …
Read More »Snow Lake Launches Kadmos Energy Services – Entering the Nuclear Power Sector with a Bold Vision
Winnipeg, Manitoba–(Newsfile Corp. – October 21, 2025) – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, announces a major strategic expansion with the creation of Kadmos Energy Services LLC (“Kadmos“), a new U.S. based nuclear energy company dedicated to the …
Read More »Thunder Gold Engages Micon International to Complete an NI 43-101 Mineral Resource Estimate at Tower Mountain
Thunder Bay, Ontario–(Newsfile Corp. – October 21, 2025) – Thunder Gold Corp. (TSXV: TGOL) (FSE: Z25) (OTCQB: TGOLF) (“Thunder Gold” or the “Company“) is pleased to announce that Micon International Limited (“MICON“) has been contracted to complete an NI 43-101 Mineral Resource Estimate (“MRE“) at the Company’s 100%-owned, 2,500-hectare, Tower …
Read More »Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Registration Link Below for October 28, 2025 12 PM EST Presentation and Live Q&A King of Prussia, Pennsylvania–(Newsfile Corp. – October 21, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today …
Read More »
Matribhumi Samachar English